|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07D 487/04 | (2006.01) |
| C07B 59/00 | (2006.01) | ||
| A61K 31/519 | (2006.01) | ||
| A61P 35/02 | (2006.01) |
| (11) | Number of the document | 3882249 |
| (13) | Kind of document | T |
| (96) | European patent application number | 21156398.6 |
| Date of filing the European patent application | 2013-06-14 | |
| (97) | Date of publication of the European application | 2021-09-22 |
| (45) | Date of publication and mention of the grant of the patent | 2025-05-14 |
| (46) | Date of publication of the claims translation | 2025-08-25 |
| (30) | Number | Date | Country code |
| 201261660428 P | 2012-06-15 | US | |
| 201261678795 P | 2012-08-02 | US |
| (72) |
Silverman, I. Robert , US
Liu, Julie F. , US
Morgan, Adam J. , US
Pandya, Bhaumik , US
Harbeson, Scott L. , US
|
| (73) |
Sun Pharmaceutical Industries, Inc. ,
2 Independence Way, Princeton, NJ 08540,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Ruksolitinibo deuterinti dariniai |
| DEUTERATED DERIVATIVES OF RUXOLITINIB |
| Payment date | Validity (years) | Amount | |
| 2025-06-26 | 13 | 289.00 EUR |
| 2026-06-14 |